September 2019, Vol. 32(Suppl. 3): 01-36


NÚMERO COMPLETO // FULL ISSUE (PDF)

Introduction

PEDRO LLINARES, JOSÉ BARBERÁN, JOSÉ MENSA

Rev Esp Quimioter 2019; 32 (Suppl. 3): 1-2.

Mechanisms of action and antimicrobial activity of ceftobiprole

MARÍA-ISABEL MOROSINI, MARÍA DÍEZ-AGUILAR, RAFAEL CANTÓN

Rev Esp Quimioter 2019; 32 (Suppl. 3): 3-10.

Ceftobiprole: pharmacokinetics and PK/PD profile

JOSÉ RAMÓN AZANZA PEREA, BELÉN SÁDABA DÍAZ DE RADA

Rev Esp Quimioter 2019; 32 (Suppl. 3): 11-16.

Ceftobiprole for the treatment of pneumonia

CATIA CILLÓNIZ, CRISTINA DOMINEDÒ, CAROLINA GARCIA-VIDAL, ANTONI TORRES

Rev Esp Quimioter 2019; 32 (Suppl. 3): 17-23.

Ceftobripole: Experience in staphylococcal bacteremia

ALEX SORIANO, LAURA MORATA

Rev Esp Quimioter 2019; 32 (Suppl. 3): 24-28.

Possible clinical indications of ceftobiprole

JOSÉ BARBERÁN

Rev Esp Quimioter 2019; 32 (Suppl. 3): 29-33.

Safety and tolerability of ceftobiprole

SANTIAGO GRAU

Rev Esp Quimioter 2019; 32 (Suppl. 3): 34-36.